GeneDx to Participate in Upcoming Investor Conference
GeneDx to Participate in Upcoming Investor Conference
At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world's largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram.STAMFORD, Conn.--(BUSINESS WIRE)--Nov. 22, 2024--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in the Piper Sandler 36th Annual Healthcare Conference from December 3-5 in New York City, NY. Management will participate in a fireside chat on Tuesday, December 3, 2024, at 1:00 p.m. ET.
康涅狄格州斯坦福德--(美國商業資訊)--2024年11月22日--通過基因組洞察改善健康狀況的領導者GenedX（納斯達克股票代碼：WGS）今天宣佈，公司管理層將參加12月3日至5日在紐約州紐約市舉行的派珀·桑德勒第36屆年度醫療保健會議。管理層將於美國東部時間2024年12月3日星期二下午 1:00 參加爐邊談話。
Live and archived webcasts will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events.
直播和存檔的網絡直播將在GenedX投資者關係網站ir.genedx.com/news-events/events/events的 「活動」 欄目上播出。
About GeneDx
關於 GenedX
At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world's largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram.
在GenedX（納斯達克股票代碼：WGS），我們相信每個人都應該得到個性化、有針對性的醫療服務，而這一切都始於基因診斷。在世界上最大的罕見病數據集之一的推動下，我們行業領先的外顯子組和基因組測試將複雜的基因組數據轉化爲臨床答案，從而解鎖個性化健康計劃，加速藥物發現，提高衛生系統效率。欲了解更多信息，請訪問 genedx.com 並通過 LinkedIn、X、Facebook 和 Instagram 聯繫我們。
View source version on businesswire.com:
在 businesswire.com 上查看源版本：
Investor Relations:
investors@GeneDx.com
投資者關係：
investors@GeneDx.com
Media:
press@GeneDx.com
媒體：
press@GeneDx.com
Source: GeneDx
資料來源：GenedX
